Companies find remarkable results are a feature of how they capture and monitor clinical data during clinical trials; especially when they implement electronic data capture. Most sponsors describe their use of CROs as a strategic, rather than a tactical decision. However, most sponsors also view CROs as considerably more expensive than in-house resources. Does EDC actually allow a sponsor to do anything they just can’t do with paper?
Please complete the form to download this white paper.